Semaglutide race: Torrent grabs 38% market share
Mumbai: Ahmedabad-based drug maker Torrent Pharma has taken a significant early lead in the generic semaglutide market, grabbing a nearly 38% share within a month of launch, as per industry data accessed by ET. Over a dozen Indian companies have launched generic versions of the GLP1 drug used for diabetes and weight management since the expiry of Novo Nordisk's patent…
Key Insights
- This topic is currently trending
- Experts are closely monitoring developments
- It may impact future decisions
